Authors
Carlos A Rivera López, Michelle I Higgins, Yuezhou Jing, Mark N Alshak, Joseph G Cheaib, Mufaddal Mamawala, Patricia Landis, Mohammad E Allaf, Katarzyna J Macura, Christian P Pavlovich
Published in
BJUI compass. Volume 7. Issue 9. Pages e70281. Epub Sep 18, 2026.
Abstract
This study aims to evaluate the performance of biparametric magnetic resonance imaging (bpMRI) compared to multiparametric MRI (mpMRI) for active surveillance (AS) in prostate cancer (PCa), focusing on lesion detection, PI-RADS classification changes and grade reclassification (GR) rates.
We retrospectively reviewed our institutional AS database for men who underwent mpMRI followed by bpMRI. Lesion counts and PI-RADS classification were compared. Second, a subgroup of men who underwent mpMRI, biopsy, bpMRI and then repeat biopsy ('bpMRI biopsy group') was matched to a control group who underwent mpMRI, biopsy, another mpMRI and then repeat biopsy ('mpMRI biopsy group') based on age, PSA density, year of diagnosis and number of positive cores. GR rates at systematic and targeted biopsy of all PI-RADS 3-5 lesions were compared, as were PI-RADS changes.
A total of 129 men with a median of 29 months between mpMRI and bpMRI were included. mpMRI identified 77 PI-RADS 3-5 lesions versus 114 on subsequent bpMRI (0.60 vs. 0.88 lesions/patient, p = 0.01); however, lesion distribution was similar, with rates of PI-RADS 3, 4 and 5 lesions of 53%, 40% and 6% on mpMRI and 53%, 37% and 11% on subsequent bpMRI (p = 0.87, 0.29 and 0.23, respectively). In the matched biopsy subgroups, when comparing men who had two surveillance mpMRIs with those who had a surveillance mpMRI followed by a surveillance bpMRI, lesion stability was not significantly different across PI-RADS categories. GR at last biopsy occurred in 29% of the bpMRI biopsy group versus in 25% of the mpMRI biopsy group (p = 0.7).
bpMRI appears safe to incorporate into AS over the short term, as it was noninferior to mpMRI with similar GR rates and lesion stability.
PMID:
42763568
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 9
- Comments 0